摘要
目的探讨依达拉奉联合脑血疏口服液治疗脑出血的临床治疗效果。方法随机选取2012年1月—2013年12月我院收治的脑出血患者260例,随机分成两组,每组130例,对照组给予常规治疗,观察组在常规治疗的基础上给予依达拉奉和脑血疏口服液,对两组患者的临床治疗效果进行比较。结果观察组的总有效率和对照组的总有效率分别为96.2%和70.8%,观察组明显优于对照组,且差异有统计学意义(P<0.05)。结论给予脑出血患者依达拉奉联合脑血疏口服液治疗可明显的改善患者的临床症状,值得应用。
Objective To investigate the clinical effect of edaravone combined with naoxueshu oral liquid in the treatment of cerebral hemorrhage. Methods 260 patients with cerebral hemorrhage admitted to our hospital from January 2012 and December 2013 were randomly divided into two groups with 130 in each one. The control group was given conventional therapy, while the observation was treated with edaravone combined with naoxueshu oral liquid on the basis of conventional treatment. Results The clinical curative effect （96.2% vs 70.8%） was evidently higher in the observation group than in the control group, and the difference was statistically significant, P〈0.05. Conclusion Edaravone combined with naoxueshu oral liquid in the treatment of cerebral hemorrhage can significantly improve their clinical symptoms, therefore it is worthy of ap-plication.
出处
《中外医疗》
2015年第32期125-126,共2页
China & Foreign Medical Treatment
关键词
依达拉奉
脑血疏口服液
脑出血
Edaravone
Naoxueshu oral liquid
Cerebral hemorrhage
